Dual Immune Checkpoint Inhibition for the First Line Treatment of BRAF Wild Type and BRAF Mutant Metastatic Melanoma.
Reference:
14-01
Session:
Session 14: Checkpoint Inhibitors for Cancer Metastasis, Speaker Steven J. O'Day, MD, Sponsored by Bristol-Myers Squibb
Presenter/s:
Steven O'Day
Presentation type:
Invited Speaker Presentation
Room:
Crystal Ballroom
Date:
Friday, April 21, 2017
Time:
12:20 - 12:40
Session times:
12:20 - 13:30